✦ LIBER ✦

Effect of foxo1 polymorphism on efficacy of acetylcholinesterase inhibitors in older patients with Alzheimer's disease

✍ Scribed by G. Paroni; G. D’Onofrio; D. Seripa; S. Bazzano; M. Urbano; C. Gravina; A. Pilotto; D. Sancarlo

Book ID: 118436087
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 77 KB
Volume: 3
Category: Article
ISSN: 1878-7649
DOI: 10.1016/j.eurger.2012.07.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormalities of acetylcholinesterase in

Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor

✍ Yasuyo Mimori; Shigenobu Nakamura; Motoko Yukawa 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 500 KB

The efficacy of galantamine in patients

The efficacy of galantamine in patients with Alzheimer's disease is independent of prior exposure to acetylcholinesterase inhibitors

✍ J.E. Mintzer; W. Yuan; P. Kershaw 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Effects of acetylcholinesterase inhibito

Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients

✍ Babiloni, Claudio; Del Percio, Claudio; Bordet, Regis; Bourriez, Jean-Luis; Bent 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Amyloid precursor protein in platelets o

Amyloid precursor protein in platelets of patients with Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors (donepezil) treatment

✍ Alessandro Padovani; Barbara Borroni; Francesca Colciaghi; Lucia Pastorino; Elis 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 372 KB

0718 Efficacy of acetylcholinesterase in

0718 Efficacy of acetylcholinesterase inhibitor therapy on activities of daily living in patients with Alzheimer's disease in Sri Lanka and impact on caregiver burden

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB

The efficacy of galantamine in the treat

The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure

✍ J. E. Mintzer; P. Kershaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to